BioNTech SE: xbrl:AdjustmentsForSharebasedPayments
| Value | {"unit": "EUR", "value": 30236000} |
|---|---|
| Period | 2019-01-01 – 2019-12-31 |
| Status | superseded |
| Entity | BioNTech SE |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:00:18.839472+02:00
Raw response sha256:
Cite as: FACTANKER, https://factanker.com/fact/e13416b3-108c-4d05-a137-bf0baf96abfd
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001564590-21-016723Retrieved: 2026-08-19T18:00:18.839472+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Cite as: FACTANKER, https://factanker.com/fact/e13416b3-108c-4d05-a137-bf0baf96abfd
History
- supersedes {"unit": "EUR", "value": 30235000} (evidence 0001564590-20-014536)